Review



channel rotem delta device  (Rotem Industries)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Rotem Industries channel rotem delta device
    Comparison of the effect of PN-1 inhibition on <t>rotational</t> <t>thromboelastometry</t> parameters between patients with cirrhosis and healthy individuals on platelet-rich plasma. (A) Illustration of the action of PN-1 on fibrinolysis. (B) <t>Rotational</t> <t>thromboelastometry</t> plot in healthy individuals and patients with cirrhosis without and with anti-PN-1 antibody/tPA. Changes in lysis onset time, lysis index at 30 min, lysis index at 45 min, maximum lysis, and lysis time values with anti-PN-1 antibody vs. irrelevant IgG (C) without and (D) with tPA. In the condition without tPA, lysis onset time occurred in five healthy individuals and nine patients with cirrhosis. Comparisons were made using the Mann–Whitney U test. IgG, immunoglobulin g; PN-1, protease nexin 1; tPA, tissue plasminogen activator.
    Channel Rotem Delta Device, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rotem%C2%AE+delta+device/delta+rotem+tpa/pmc12639314-134-5-6
    Average 86 stars, based on 1 article reviews
    channel rotem delta device - by Bioz Stars, 2026-10
    86/100 stars

    Images

    1) Product Images from "Platelet protease nexin-1 limits fibrinolysis in patients with cirrhosis ☆ "

    Article Title: Platelet protease nexin-1 limits fibrinolysis in patients with cirrhosis ☆

    Journal: JHEP Reports

    doi: 10.1016/j.jhepr.2025.101563

    Comparison of the effect of PN-1 inhibition on rotational thromboelastometry parameters between patients with cirrhosis and healthy individuals on platelet-rich plasma. (A) Illustration of the action of PN-1 on fibrinolysis. (B) Rotational thromboelastometry plot in healthy individuals and patients with cirrhosis without and with anti-PN-1 antibody/tPA. Changes in lysis onset time, lysis index at 30 min, lysis index at 45 min, maximum lysis, and lysis time values with anti-PN-1 antibody vs. irrelevant IgG (C) without and (D) with tPA. In the condition without tPA, lysis onset time occurred in five healthy individuals and nine patients with cirrhosis. Comparisons were made using the Mann–Whitney U test. IgG, immunoglobulin g; PN-1, protease nexin 1; tPA, tissue plasminogen activator.
    Figure Legend Snippet: Comparison of the effect of PN-1 inhibition on rotational thromboelastometry parameters between patients with cirrhosis and healthy individuals on platelet-rich plasma. (A) Illustration of the action of PN-1 on fibrinolysis. (B) Rotational thromboelastometry plot in healthy individuals and patients with cirrhosis without and with anti-PN-1 antibody/tPA. Changes in lysis onset time, lysis index at 30 min, lysis index at 45 min, maximum lysis, and lysis time values with anti-PN-1 antibody vs. irrelevant IgG (C) without and (D) with tPA. In the condition without tPA, lysis onset time occurred in five healthy individuals and nine patients with cirrhosis. Comparisons were made using the Mann–Whitney U test. IgG, immunoglobulin g; PN-1, protease nexin 1; tPA, tissue plasminogen activator.

    Techniques Used: Comparison, Inhibition, Clinical Proteomics, Lysis, MANN-WHITNEY

    Related Articles

    Coagulation:

    Article Title: Basic Principles of Rotational Thromboelastometry (ROTEM ® ) and the Role of ROTEM-Guided Fibrinogen Replacement Therapy in the Management of Coagulopathies.
    Article Snippet: The reference values for the ROTEM® delta device in adult patients are listed in Table 2.

    Article Title: Inhibitors of transglutaminases
    Article Snippet: The potency of selected compounds (serial dilution covering 6.25 μM to 50 μM final concentration) in the presence of 0.02 μg/ml tissue plasminogen activator (t-PA, Zedira product P016) were investigated.

    Article Title: Comparison of ROTEM® Delta and ROTEM® Sigma transfusion algorithm performance in thoracic aortic surgery: a single-centre prospective observational cohort study.
    Article Snippet: Its implementation has proven to reduce blood loss and transfusion of red blood cells in this high-risk population.1e4 The ROTEM® Delta device needs Table 2 Proportions of algorithm deviations, defined as different haemostatic therapy advice when following ROTEM® Sigma as opposed to ROTEM® Delta.

    Article Title: Diagnostic performance of thromboelastometry in trauma-induced coagulopathy: a comparison between two level I trauma centres using two different devices.
    Article Snippet: Purpose The implementation of a ROTEM®-based algorithm requires reliable thresholds to mirror a prothrombin time (PT) ratio > 1.2 and/or a fibrinogen concentration < 1.5 g l−1.. Our goal was to compare the diagnostic performances of two devices (ROTEM® Sigma and Delta, IL Werfen, Munich, Germany) in two level-I trauma centres for the diagnostic of posttraumatic coagulopathy.. Methods We conducted a retrospective analysis of two registries across two periods of time: from September 2014 to December 2015 in Lyon-Sud university trauma centre and from April 2016 to January 2018 in the Grenoble Alps Trauma Centre.

    Article Title: Rotational thromboelastometry (ROTEM) in pediatric intensive care: A single center experience.
    Article Snippet: The study aimed to analyze ROTEM’s impact on transfusion practices and investigate the correlation between standard coagulation tests and ROTEM parameters.. We designed it as a retrospective descriptive study, using single-center data from January 2021 to February 2023.. All critically ill children admitted to PICU who underwent ROTEM analysis as part of their diagnostic and therapeutic management were included in the study.

    Article Title: Reference intervals for rotational thromboelastometry measurements using the ROTEM® delta device in dogs.
    Article Snippet: Aims of the present study were to define reference intervals for viscoelastic analyses of canine haemostasis using the ROTEM® delta analyser, and as a secondary aspect to determine the precision (repeatability) of this method.. Blood samples from 125 clinically healthy dogs were included.. Measurements were performed with commercially available activating reagents (ex-tem, in-tem and kaolin solution) as well as without activation.

    Article Title: Inhibitors of blood coagulation factor XIII
    Article Snippet: Clotting time (CT), clot formation time (CFT), maximum clot firmness (MCF) and lysis index at 60 min (LI60) were obtained using fresh whole blood in the ROTEM® delta device according to the manufacturer's instructions.

    Lysis:

    Article Title: Basic Principles of Rotational Thromboelastometry (ROTEM ® ) and the Role of ROTEM-Guided Fibrinogen Replacement Therapy in the Management of Coagulopathies.
    Article Snippet: The reference values for the ROTEM® delta device in adult patients are listed in Table 2.

    Article Title: Inhibitors of transglutaminases
    Article Snippet: The potency of selected compounds (serial dilution covering 6.25 μM to 50 μM final concentration) in the presence of 0.02 μg/ml tissue plasminogen activator (t-PA, Zedira product P016) were investigated.

    Article Title: Comparison of ROTEM® Delta and ROTEM® Sigma transfusion algorithm performance in thoracic aortic surgery: a single-centre prospective observational cohort study.
    Article Snippet: Its implementation has proven to reduce blood loss and transfusion of red blood cells in this high-risk population.1e4 The ROTEM® Delta device needs Table 2 Proportions of algorithm deviations, defined as different haemostatic therapy advice when following ROTEM® Sigma as opposed to ROTEM® Delta.

    Article Title: Diagnostic performance of thromboelastometry in trauma-induced coagulopathy: a comparison between two level I trauma centres using two different devices.
    Article Snippet: Purpose The implementation of a ROTEM®-based algorithm requires reliable thresholds to mirror a prothrombin time (PT) ratio > 1.2 and/or a fibrinogen concentration < 1.5 g l−1.. Our goal was to compare the diagnostic performances of two devices (ROTEM® Sigma and Delta, IL Werfen, Munich, Germany) in two level-I trauma centres for the diagnostic of posttraumatic coagulopathy.. Methods We conducted a retrospective analysis of two registries across two periods of time: from September 2014 to December 2015 in Lyon-Sud university trauma centre and from April 2016 to January 2018 in the Grenoble Alps Trauma Centre.

    Article Title: Rotational thromboelastometry (ROTEM) in pediatric intensive care: A single center experience.
    Article Snippet: The study aimed to analyze ROTEM’s impact on transfusion practices and investigate the correlation between standard coagulation tests and ROTEM parameters.. We designed it as a retrospective descriptive study, using single-center data from January 2021 to February 2023.. All critically ill children admitted to PICU who underwent ROTEM analysis as part of their diagnostic and therapeutic management were included in the study.

    Article Title: Reference intervals for rotational thromboelastometry measurements using the ROTEM® delta device in dogs.
    Article Snippet: Aims of the present study were to define reference intervals for viscoelastic analyses of canine haemostasis using the ROTEM® delta analyser, and as a secondary aspect to determine the precision (repeatability) of this method.. Blood samples from 125 clinically healthy dogs were included.. Measurements were performed with commercially available activating reagents (ex-tem, in-tem and kaolin solution) as well as without activation.

    Article Title: Inhibitors of blood coagulation factor XIII
    Article Snippet: Clotting time (CT), clot formation time (CFT), maximum clot firmness (MCF) and lysis index at 60 min (LI60) were obtained using fresh whole blood in the ROTEM® delta device according to the manufacturer's instructions.



    Similar Products

    channel rotem delta device  (Rotem Industries)
    86
    Rotem Industries channel rotem delta device
    Comparison of the effect of PN-1 inhibition on <t>rotational</t> <t>thromboelastometry</t> parameters between patients with cirrhosis and healthy individuals on platelet-rich plasma. (A) Illustration of the action of PN-1 on fibrinolysis. (B) <t>Rotational</t> <t>thromboelastometry</t> plot in healthy individuals and patients with cirrhosis without and with anti-PN-1 antibody/tPA. Changes in lysis onset time, lysis index at 30 min, lysis index at 45 min, maximum lysis, and lysis time values with anti-PN-1 antibody vs. irrelevant IgG (C) without and (D) with tPA. In the condition without tPA, lysis onset time occurred in five healthy individuals and nine patients with cirrhosis. Comparisons were made using the Mann–Whitney U test. IgG, immunoglobulin g; PN-1, protease nexin 1; tPA, tissue plasminogen activator.
    Channel Rotem Delta Device, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rotem%C2%AE+delta+device/delta+rotem+tpa/pmc12639314-134-5-6
    Average 86 stars, based on 1 article reviews
    channel rotem delta device - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    rotem delta device  (Rotem Industries)
    86
    Rotem Industries rotem delta device
    Comparison of the effect of PN-1 inhibition on <t>rotational</t> <t>thromboelastometry</t> parameters between patients with cirrhosis and healthy individuals on platelet-rich plasma. (A) Illustration of the action of PN-1 on fibrinolysis. (B) <t>Rotational</t> <t>thromboelastometry</t> plot in healthy individuals and patients with cirrhosis without and with anti-PN-1 antibody/tPA. Changes in lysis onset time, lysis index at 30 min, lysis index at 45 min, maximum lysis, and lysis time values with anti-PN-1 antibody vs. irrelevant IgG (C) without and (D) with tPA. In the condition without tPA, lysis onset time occurred in five healthy individuals and nine patients with cirrhosis. Comparisons were made using the Mann–Whitney U test. IgG, immunoglobulin g; PN-1, protease nexin 1; tPA, tissue plasminogen activator.
    Rotem Delta Device, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rotem%C2%AE+delta+device/delta+rotem+tpa/pm41096610-170-7-7
    Average 86 stars, based on 1 article reviews
    rotem delta device - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    rotem® delta device  (Rotem Industries)
    90
    Rotem Industries rotem® delta device
    Comparison of the effect of PN-1 inhibition on <t>rotational</t> <t>thromboelastometry</t> parameters between patients with cirrhosis and healthy individuals on platelet-rich plasma. (A) Illustration of the action of PN-1 on fibrinolysis. (B) <t>Rotational</t> <t>thromboelastometry</t> plot in healthy individuals and patients with cirrhosis without and with anti-PN-1 antibody/tPA. Changes in lysis onset time, lysis index at 30 min, lysis index at 45 min, maximum lysis, and lysis time values with anti-PN-1 antibody vs. irrelevant IgG (C) without and (D) with tPA. In the condition without tPA, lysis onset time occurred in five healthy individuals and nine patients with cirrhosis. Comparisons were made using the Mann–Whitney U test. IgG, immunoglobulin g; PN-1, protease nexin 1; tPA, tissue plasminogen activator.
    Rotem® Delta Device, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rotem%C2%AE+delta+device/rotem+delta+device/pm40578147-60-1-1
    Average 90 stars, based on 1 article reviews
    rotem® delta device - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    viscoelastic device rotem® delta  (Rotem Industries)
    90
    Rotem Industries viscoelastic device rotem® delta
    Comparison of the effect of PN-1 inhibition on <t>rotational</t> <t>thromboelastometry</t> parameters between patients with cirrhosis and healthy individuals on platelet-rich plasma. (A) Illustration of the action of PN-1 on fibrinolysis. (B) <t>Rotational</t> <t>thromboelastometry</t> plot in healthy individuals and patients with cirrhosis without and with anti-PN-1 antibody/tPA. Changes in lysis onset time, lysis index at 30 min, lysis index at 45 min, maximum lysis, and lysis time values with anti-PN-1 antibody vs. irrelevant IgG (C) without and (D) with tPA. In the condition without tPA, lysis onset time occurred in five healthy individuals and nine patients with cirrhosis. Comparisons were made using the Mann–Whitney U test. IgG, immunoglobulin g; PN-1, protease nexin 1; tPA, tissue plasminogen activator.
    Viscoelastic Device Rotem® Delta, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rotem%C2%AE+delta+device/rotem+delta+device/pm40098153-420-18-20
    Average 90 stars, based on 1 article reviews
    viscoelastic device rotem® delta - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    viscoelastic device rotem delta  (Rotem Industries)
    90
    Rotem Industries viscoelastic device rotem delta
    Comparison of the effect of PN-1 inhibition on <t>rotational</t> <t>thromboelastometry</t> parameters between patients with cirrhosis and healthy individuals on platelet-rich plasma. (A) Illustration of the action of PN-1 on fibrinolysis. (B) <t>Rotational</t> <t>thromboelastometry</t> plot in healthy individuals and patients with cirrhosis without and with anti-PN-1 antibody/tPA. Changes in lysis onset time, lysis index at 30 min, lysis index at 45 min, maximum lysis, and lysis time values with anti-PN-1 antibody vs. irrelevant IgG (C) without and (D) with tPA. In the condition without tPA, lysis onset time occurred in five healthy individuals and nine patients with cirrhosis. Comparisons were made using the Mann–Whitney U test. IgG, immunoglobulin g; PN-1, protease nexin 1; tPA, tissue plasminogen activator.
    Viscoelastic Device Rotem Delta, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rotem%C2%AE+delta+device/teg+6s/pm39755516-4-19-21
    Average 90 stars, based on 1 article reviews
    viscoelastic device rotem delta - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Comparison of the effect of PN-1 inhibition on rotational thromboelastometry parameters between patients with cirrhosis and healthy individuals on platelet-rich plasma. (A) Illustration of the action of PN-1 on fibrinolysis. (B) Rotational thromboelastometry plot in healthy individuals and patients with cirrhosis without and with anti-PN-1 antibody/tPA. Changes in lysis onset time, lysis index at 30 min, lysis index at 45 min, maximum lysis, and lysis time values with anti-PN-1 antibody vs. irrelevant IgG (C) without and (D) with tPA. In the condition without tPA, lysis onset time occurred in five healthy individuals and nine patients with cirrhosis. Comparisons were made using the Mann–Whitney U test. IgG, immunoglobulin g; PN-1, protease nexin 1; tPA, tissue plasminogen activator.

    Journal: JHEP Reports

    Article Title: Platelet protease nexin-1 limits fibrinolysis in patients with cirrhosis ☆

    doi: 10.1016/j.jhepr.2025.101563

    Figure Lengend Snippet: Comparison of the effect of PN-1 inhibition on rotational thromboelastometry parameters between patients with cirrhosis and healthy individuals on platelet-rich plasma. (A) Illustration of the action of PN-1 on fibrinolysis. (B) Rotational thromboelastometry plot in healthy individuals and patients with cirrhosis without and with anti-PN-1 antibody/tPA. Changes in lysis onset time, lysis index at 30 min, lysis index at 45 min, maximum lysis, and lysis time values with anti-PN-1 antibody vs. irrelevant IgG (C) without and (D) with tPA. In the condition without tPA, lysis onset time occurred in five healthy individuals and nine patients with cirrhosis. Comparisons were made using the Mann–Whitney U test. IgG, immunoglobulin g; PN-1, protease nexin 1; tPA, tissue plasminogen activator.

    Article Snippet: ROTEM was conducted using the four-channel ROTEM® Delta device.

    Techniques: Comparison, Inhibition, Clinical Proteomics, Lysis, MANN-WHITNEY